Home
Biotechnology Value Fund reported a 4.1% stake in Protagonist Therapeutics PTGX · 2,560,916 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.1%
- Last report
- 5.2% · filed 25/06/16
- Shares held
- 2,560,916 sh
- Class
- Common Stock, $0.00001 par value per share
- Holder
- Biotechnology Value Fund
- Event date
- 25/09/30
- Filed
- 25/11/14
4.1% stake · below 5%
- Stake
- 4.1%
- Last report
- 5.2%
- Since last report
- −1.1pp
Protagonist Therapeutics trades, last 26 weeks
What else happened in Protagonist Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Biotechnology Value Fund's other 5% stake reports
- Biotechnology Value Fund
5% stakeStoke Therapeutics
5% stakeStoke Therapeutics
STOK
5.6% stake
3,608,968 sh
5.6% stake
Filed 09/30
- Biotechnology Value Fund
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
6.1% stake
4,215,886 sh
6.1% stake
Filed 09/21
- Biotechnology Value Fund
5% stakeAlector
5% stakeAlector
ALEC
8.4% stake
9,374,267 sh
8.4% stake
Filed 09/18
- Biotechnology Value Fund
5% stakePalvella Therapeutics
5% stakePalvella Therapeutics
PVLA
4.7% stake
672,789 sh
4.7% stake
Filed 08/14
- Biotechnology Value Fund
5% stakeOnKure Therapeutics
5% stakeOnKure Therapeutics
OKUR
8% stake
3,235,778 sh
8% stake
Filed 08/14
